Sarepta Therapeutics Balance Sheet (2010-2025) | SRPT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter)	1,481.84M	1,697.28M	1,599.11M	2,115.87M	1,233.88M	868.57M	1,038.62M	966.78M	871.67M	851.93M	541.93M	428.43M	427.29M	383.62M	197.85M	844.19M	612.27M	510.60M	613.10M	801.28M
Short-term Investments (Quarter)	256.00M	30.00M			779.55M	1,059.45M	1,033.90M	1,022.60M	1,010.43M	1,008.79M	1,191.61M	1,247.82M	963.50M	1,076.90M	44.62M	251.78M	281.89M	289.54M	237.92M	138.37M
Cash & Current Investments (Quarter)	1,737.83M	1,727.28M	1,599.11M	2,115.87M	2,013.42M	1,928.02M	2,072.52M	1,989.37M	1,882.10M	1,860.71M	1,733.54M	1,676.25M	1,390.79M	1,460.52M	242.48M	1,095.97M	894.16M	800.14M	851.02M	939.65M
Receivables - Net (Quarter)	118.20M	127.52M	149.79M	152.99M	178.20M	203.85M	201.50M	214.60M	223.80M	236.80M	318.90M	400.33M	378.81M	360.00M	434.50M	601.99M	659.40M	527.29M	395.70M	398.23M
Receivables - Other (Quarter)	15.10M	17.70M	29.10M	0.01M	17.70M	26.40M	21.90M	41.80M	62.00M	28.60M	35.40M	29.80M	30.10M	19.90M	66.40M	34.60M	55.20M	73.30M	128.70M	104.10M
Receivables (Quarter)	133.30M	145.22M	178.89M	153.00M	195.90M	230.25M	223.40M	256.40M	285.80M	265.40M	354.30M	430.13M	408.91M	379.90M	500.90M	636.59M	714.60M	600.60M	524.40M	502.33M
Raw Materials (Quarter)	62.24M	191.51M	40.16M	230.19M	245.27M	253.20M	57.98M	59.18M	239.66M	243.06M	114.62M	133.96M	150.01M	167.20M	208.32M	280.05M	298.98M	314.85M	325.54M	141.28M
Work In Process (Quarter)								269.19M				318.46M		470.38M	482.17M	610.69M	762.23M	802.87M	885.42M	892.69M
Finished Goods (Quarter)	28.28M	29.47M	26.83M	26.72M	33.88M	35.50M	49.26M	38.15M	42.69M	47.61M	47.24M	61.81M	39.50M	52.90M	77.98M	47.21M	61.37M	70.98M	64.80M	65.32M
Inventory (Quarter)	240.33M	268.76M	288.47M	186.21M	199.00M	208.09M	221.19M	203.97M	202.68M	226.88M	244.01M	322.86M	373.53M	485.80M	565.92M	749.96M	941.43M	994.04M	1,077.17M	914.74M
Prepaid Assets (Quarter)	174.98M	141.67M	147.94M	149.03M	0.38M	129.33M	130.74M	3.72M	179.77M	148.22M	1.54M	77.71M	82.97M	74.74M	165.48M	90.46M	105.48M	4.11M	192.35M	171.86M
Current Assets (Quarter)	2,271.35M	2,265.22M	2,185.31M	2,604.10M	2,530.95M	2,469.30M	2,625.93M	2,557.86M	2,488.38M	2,472.61M	2,450.85M	2,579.33M	2,464.86M	2,683.64M	2,685.37M	3,073.46M	2,432.53M	2,656.99M	2,722.31M	2,537.94M
Non-Current Assets
Construction in Progress (Quarter)
Property, Plant & Equipment (Net) (Quarter)	203.11M	203.33M	199.25M	191.16M	187.25M	183.29M	181.00M	180.04M	182.86M	188.87M	212.37M	227.15M	249.30M	276.20M	305.79M	340.34M	360.59M	371.86M	358.94M	345.12M
Long-Term Investments (Quarter)	9.31M	39.97M	9.30M	34.89M	9.65M	18.50M	19.02M	31.32M	31.00M	31.00M	7.50M		7.46M	7.61M	4.72M	133.16M	391.00M	195.52M	8.16M	1.05M
Intangibles (Quarter)	14.12M	14.11M	14.20M	14.24M	13.33M	13.06M	13.06M	7.58M	7.20M	18.02M	19.50M	10.00M	28.93M	28.25M	27.57M	26.89M	26.20M	30.52M	29.68M	19.00M
Goodwill & Intangibles (Quarter)	14.12M	14.11M	14.20M	14.24M	13.33M	13.06M	13.06M	7.58M	7.20M	18.02M	19.50M	10.00M	28.93M	28.25M	27.57M	26.89M	26.20M	30.52M	29.68M	19.00M
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)	211.58M	3.42M	190.79M	2.01M	278.65M	3.54M	4.22M	162.97M	8.57M	163.04M	3.77M	136.77M	15.58M	3.14M	15.58M	1.14M	80.55M	83.14M	4.17M	5.19M
Non-Current Assets (Quarter)	493.88M	493.86M	476.91M	543.88M	525.21M	527.55M	530.22M	570.50M	571.41M	653.28M	658.86M	685.25M	759.52M	740.62M	914.57M	889.71M	1,032.85M	1,022.83M	771.13M	811.76M
Assets (Quarter)	2,765.23M	2,759.07M	2,662.22M	3,147.97M	3,056.15M	2,996.85M	3,156.15M	3,128.37M	3,059.79M	3,125.89M	3,109.71M	3,264.58M	3,224.39M	3,424.26M	3,599.93M	3,963.17M	3,465.39M	3,679.81M	3,493.44M	3,349.70M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	76.65M	76.68M	44.16M	76.74M	54.01M	56.21M	118.46M	95.88M	106.71M	109.80M	87.95M	164.92M	91.54M	107.42M	118.77M	214.44M	156.10M	136.70M	94.02M	280.84M
Notes Payables (Quarter)
Payables (Quarter)	76.65M	76.68M	44.16M	76.74M	54.01M	56.21M	118.46M	95.88M	106.71M	109.80M	87.95M	164.92M	91.54M	107.42M	118.77M	214.44M	156.10M	136.70M	94.02M	280.84M
Accumulated Expenses (Quarter)	180.64M	240.14M	3.18M	271.70M	19.18M	383.70M	369.00M	65.95M	8.38M	44.91M	10.50M	12.07M	32.11M	350.40M	344.83M	91.12M	35.30M	4.73M	30.96M	359.66M
Other Accumulated Expenses (Quarter)	3.95M	4.35M	6.04M	15.05M	17.80M	16.42M	4.34M	5.31M	17.38M	16.99M	7.72M	17.84M	5.88M	17.13M	17.29M	13.47M	10.02M	5.93M	10.24M	7.96M
Short term Debt (Quarter)												105.48M	105.59M	91.50M	91.59M				36.00M
Current Leases (Quarter)								15.49M				17.84M
Current Taxes (Quarter)				0.22M			4.09M	12.52M	16.09M	20.82M	24.68M	13.77M	18.29M			17.39M	79.86M	18.73M	9.09M
Current Deferred Revenue (Quarter)	89.24M	89.24M	89.24M	89.24M	89.24M	89.24M	89.24M	89.24M	67.24M	44.99M	22.49M	50.42M	112.00M	122.04M	127.00M	130.26M	44.86M	395.43M	485.45M	443.40M
Total Current Liabilities (Quarter)	364.74M	425.02M	373.44M	452.73M	454.96M	545.57M	602.92M	619.60M	536.88M	498.65M	450.74M	653.66M	608.71M	688.49M	699.49M	731.68M	605.59M	919.95M	921.42M	1,095.29M
Non-Current Liabilities
Non-Current Debt (Quarter)	1,091.11M	1,092.98M	1,094.91M	1,096.88M	1,098.85M	1,100.87M	1,542.77M	1,544.29M	1,234.28M	1,235.52M	1,236.76M	1,132.52M	1,133.66M	1,134.81M	1,135.96M	1,137.12M	1,138.29M	1,139.46M	1,035.15M	828.97M
Non-Current Deffered Revenue (Quarter)	641.48M	619.23M	596.74M	574.24M	552.24M	529.99M	507.49M	485.00M	485.00M	485.00M	485.00M	437.00M	325.00M	325.00M	325.00M	325.00M	325.00M			83.91M
Operating Leases (Quarter)	60.67M	65.28M	63.43M	41.51M	38.62M	39.37M	35.23M	57.58M	53.93M	129.17M	134.75M	140.97M	140.10M	143.60M	170.01M	192.47M	205.46M	214.42M	215.04M	199.38M
Other Non-Current Liabilities (Quarter)	50.80M	50.80M	43.60M	43.60M	11.00M	43.60M	36.90M	36.90M	36.90M	36.10M	38.10M	38.10M	48.20M	48.20M	47.40M	47.40M	47.40M	47.40M	0.30M	1.53M
Total Non-Current Liabilities (Quarter)	2,178.99M	2,223.16M	2,149.09M	2,176.36M	2,188.27M	2,226.80M	2,688.41M	2,706.52M	2,310.14M	2,348.38M	2,307.25M	2,367.14M	2,214.99M	2,298.99M	2,331.46M	2,388.03M	2,275.26M	2,275.03M	2,173.02M	2,207.55M
Total Liabilities (Quarter)	2,229.79M	2,273.97M	2,192.69M	2,219.97M	2,199.27M	2,270.40M	2,725.31M	2,743.42M	2,347.04M	2,384.48M	2,345.35M	2,405.24M	2,263.19M	2,347.19M	2,378.86M	2,435.43M	2,322.66M	2,322.43M	2,173.32M	2,209.08M
Shareholder's Equity
Total Debt (Quarter)	1,091.11M	1,092.98M	1,094.91M	1,096.88M	1,098.85M	1,100.87M	1,542.77M	1,544.29M	1,234.28M	1,235.52M	1,236.76M	1,238.00M	1,239.25M	1,226.32M	1,227.56M	1,137.12M	1,138.29M	1,139.46M	1,071.15M	828.97M
Common Equity (Quarter)	535.45M	485.11M	469.53M	928.01M	856.89M	726.46M	430.84M	384.95M	712.75M	741.41M	764.36M	859.34M	961.19M	1,077.07M	1,221.07M	1,527.74M	1,142.72M	1,357.38M	1,320.12M	1,140.62M
Shareholder's Equity (Quarter)	535.45M	485.11M	469.53M	928.01M	856.89M	726.46M	430.84M	384.95M	712.75M	741.41M	764.36M	859.34M	961.19M	1,077.07M	1,221.07M	1,527.74M	1,142.72M	1,357.38M	1,320.12M	1,140.62M
Liabilities and Shareholders Equity (Quarter)	2,765.23M	2,759.07M	2,662.22M	3,147.97M	3,056.15M	2,996.85M	3,156.15M	3,128.37M	3,059.79M	3,125.89M	3,109.71M	3,264.58M	3,224.39M	3,424.26M	3,599.93M	3,963.17M	3,465.39M	3,679.81M	3,493.44M	3,349.70M
Treasury Shares (Quarter)				1.32M				1.83M				2.24M						-0.65M	0.65M	5.60M
Retained Earnings (Quarter)	-0.00M	0.00M	-0.02M	-0.02M	-3311.77M	-3543.25M	-3.21M	-1.66M	-0.42M	-4450.93M	-0.64M	0.92M	-4410.09M	-4403.63M	2.25M	-0.22M	-4658.48M	-0.05M	0.22M	0.27M

Research Tools

Sarepta Therapeutics Balance Sheet (2010-2025) | SRPT

Create an account

Sign In

Reset Password